FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,639,000 | -24.4% | 122,300 | -47.5% | 0.00% | -25.0% |
| Q4 2018 | $2,167,000 | -6.6% | 233,021 | +39.7% | 0.00% | +33.3% |
| Q3 2018 | $2,321,000 | +3.4% | 166,790 | +17.4% | 0.00% | 0.0% |
| Q2 2018 | $2,245,000 | +97.6% | 142,030 | +351.9% | 0.00% | +50.0% |
| Q1 2017 | $1,136,000 | -65.0% | 31,430 | -51.5% | 0.00% | -60.0% |
| Q4 2016 | $3,247,000 | +26.3% | 64,786 | +32.3% | 0.01% | +25.0% |
| Q3 2016 | $2,571,000 | +203.2% | 48,986 | +139.0% | 0.00% | +300.0% |
| Q2 2016 | $848,000 | +31.3% | 20,492 | -51.2% | 0.00% | 0.0% |
| Q3 2015 | $646,000 | -49.9% | 42,000 | -19.1% | 0.00% | -50.0% |
| Q2 2015 | $1,289,000 | -45.6% | 51,900 | -50.0% | 0.00% | -50.0% |
| Q1 2015 | $2,370,000 | +100.8% | 103,700 | +137.3% | 0.00% | +100.0% |
| Q4 2014 | $1,180,000 | – | 43,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,781,346 | $25,867,000 | 3.38% |
| GREAT POINT PARTNERS LLC | 2,398,409 | $22,305,000 | 2.82% |
| Sofinnova Investments, Inc. | 315,344 | $2,933,000 | 0.36% |
| EcoR1 Capital, LLC | 326,775 | $3,039,000 | 0.30% |
| Rock Springs Capital Management LP | 505,000 | $4,697,000 | 0.22% |
| Hilltop Holdings Inc. | 36,146 | $336,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 285,237 | $2,653,000 | 0.07% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 191,237 | $1,779,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,132 | $113,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,427 | $292,000 | 0.05% |